Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis

Arthritis&Rheumatology, EarlyView.

Source: Arthritis and Rheumatology - April 25, 2018 Category: Rheumatology Authors: Michael E. WeinblattMD , Asta BaranauskaiteMD, PhD , Eva DokoupilovaMD , Agnieszka ZielinskaMD , Janusz JaworskiMD, PhD , Artur RacewiczMD, PhD , Margarita PileckyteMD, PhD , Krystyna Jedrychowicz ‐RosiakMD , Inyoung BaekPhD , Jeehoon Source Type: research